Initial impact of Australia’s National Bowel Cancer Screening Program

Sumitra S Ananda, Stephen J McLaughlin, Frank Chen, Ian P Hayes, Andrew A Hunter, Iain J Skinner, Malcolm C A Steel, Ian T Jones, Ian A Hastie, Nicholas A Rieger, Susan Shedda, Daniel J Compston and Peter Gibbs
Med J Aust 2009; 191 (7): 378-381.


Objective: To examine the initial impact of the National Bowel Cancer Screening Program (NBCSP), which was launched in May 2006 and offers faecal occult blood testing to Australians aged 55 or 65 years.

Design and setting: Review of data on colorectal cancer (CRC) cases diagnosed between May 2006 and June 2008 from a prospective database used at 19 Australian hospitals, linked and analysed by BioGrid Australia.

Main outcome measures: Number of CRC cases detected through the NBCSP or symptomatic presentation, and differences by sex, stage at diagnosis, tumour location and level of socioeconomic disadvantage.

Results: 1628 cases of CRC were identified; 1268 had information on the patients’ test status as part of the NBCSP, and 40 of these (3.2%) were recorded as being detected by the NBCSP. Of 75 CRC cases in patients aged 55 or 65 at diagnosis, 22 were NBCSP-detected. Overall, there was no difference in NBCSP-detected cases by sex. The distribution of tumour locations was similar between NBCSP-detected cases and symptomatic cases, but NBCSP-detected cancers were diagnosed at an earlier stage than symptomatic cancers (stage I, 40% v 14%; stage IV, 3% v 15%, respectively). Of patients diagnosed through the NBCSP, 63% were from areas of least socioeconomic disadvantage (deciles 8–10) and 18% were from the most disadvantaged areas (deciles 1–4) (P = 0.0375).

Conclusion: Initiation of the Australian NBCSP has had a measurable impact on CRC stage at diagnosis, and an improvement in survival would be anticipated. The lower uptake among people from disadvantaged areas is of concern.

  • Sumitra S Ananda1,2
  • Stephen J McLaughlin3
  • Frank Chen4
  • Ian P Hayes1
  • Andrew A Hunter5
  • Iain J Skinner3
  • Malcolm C A Steel4
  • Ian T Jones1
  • Ian A Hastie1
  • Nicholas A Rieger5,6
  • Susan Shedda1
  • Daniel J Compston2
  • Peter Gibbs1,2

  • 1 Royal Melbourne Hospital, Melbourne, VIC.
  • 2 BioGrid Australia, Melbourne, VIC.
  • 3 Western Hospital, Melbourne, VIC.
  • 4 Hill Hospital, Melbourne, VIC.
  • 5 Royal Adelaide Hospital, Adelaide, SA.
  • 6 University of Adelaide, Adelaide, SA.


Competing interests:

None identified.

  • 1. Australian Institute of Health and Welfare. Cancer in Australia: an overview, 2008. Canberra: AIHW, 2008. (AIHW Cat. No. CAN 42.) (accessed Aug 2009).
  • 2. Cancer Council Australia. National Cancer Prevention Policy 2007–09. Sydney: Cancer Council Australia, 2007. (accessed Sep 2009).
  • 3. Alexander F, Weller D, Orbell S, et al; UK CRC Screening Pilot Evaluation Team. Evaluation of the UK Colorectal Cancer Screening Pilot: final report. Edinburgh: Department of Community Health Services, 2003.
  • 4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371.
  • 5. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-437.
  • 6. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
  • 7. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471.
  • 8. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998; 317: 559-565.
  • 9. Gabe R, Duffy SW. The impact of mammographic screening on breast cancer mortality: overview of the evidence so far. Breast Cancer Res 2004; 6 Suppl 1: 7.
  • 10. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee. Australia’s Bowel Cancer Screening Pilot and beyond: final evaluation report. Canberra: Department of Health and Ageing, 2005.
  • 11. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged > 50 years — United States, 2001. MMWR Morb Mortal Wkly Rep 2003; 52: 193-196.
  • 12. Baker PG. Screening for colorectal cancer — benefit or burden? J R Coll Physicians Edinb 2004; 34: 99-103.
  • 13. Shapiro JA, Seeff LC, Thompson TD, et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008; 17: 1623-1630.
  • 14. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008; 58: 9-31.
  • 15. Turrell G, Oldenburg BF, McGuffog I, Dent R. Socioeconomic determinants of health: towards a national research program and a policy and intervention agenda. Brisbane: Queensland University of Technology, School of Public Health, 1999.
  • 16. Hart JT. The inverse care law. Lancet 1971; 1: 405-412.
  • 17. Furler JS, Harris E, Chondros P, et al. The inverse care law revisited: impact of disadvantaged location on accessing longer GP consultation times. Med J Aust 2002; 177: 80-83. <MJA full text>
  • 18. American Cancer Society. Cancer facts & figures 2008. Atlanta: ACS, 2008. secured.pdf (accessed Sep 2009).
  • 19. Harris MF, Priddin D, Ruscoe W, et al. Quality of care provided by general practitioners using or not using Division-based diabetes registers. Med J Aust 2002; 177: 250-252. <MJA full text>
  • 20. Whynes DK, Frew EJ, Manghan CM, et al. Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health 2003; 117: 389-395.
  • 21. Cancer Council Victoria. Men are putting themselves at greater risk of bowel cancer [media release]. 2 Oct 2007. (accessed Jul 2008).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.